Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
All-cause mortality | |||||
[81]
Systematic review |
4909 people 8 RCTs in this analysis |
Rate of mortality
459/2428 (19%) with implantable cardiac defibrillator (ICD) 695/2481 (28%) with usual care |
RR 0.74 95% CI 0.67 to 0.82 |
Small effect size | ICD |
[81]
Systematic review |
2946 people with evidence of heart failure or coronary artery disease (primary prevention) 5 RCTs in this analysis |
Rate of mortality
260/1494 (17%) with ICD 391/1452 (27%) with usual care |
RR 0.72 95% CI 0.63 to 0.84 The magnitude of absolute-mortality benefit increased with increasing baseline risk of sudden cardiac death There was significant heterogeneity among RCTs because 3 RCTs were in people at high risk of heart failure and 2 RCTs were in people at moderate risk of heart failure |
Small effect size | ICD |
[81]
Systematic review |
1963 people who had survived sudden cardiac death or had unstable ventricular rhythm (secondary prevention) 3 RCTs in this analysis |
Rate of mortality
199/934 (21%) with ICD 304/1029 (30%) with usual care |
RR 0.76 95% CI 0.65 to 0.89 |
Small effect size | ICD |
[82]
Systematic review |
2110 people with heart failure caused by non-ischaemic cardiomyopathy 7 RCTs in this analysis |
Rate of mortality
with ICD with usual care Absolute results not reported |
RR 0.69 95% CI 0.56 to 0.86 |
Small effect size | ICD |
[82]
Systematic review |
1457 people with heart failure caused by non-ischaemic cardiomyopathy (primary prevention) 4 RCTs in this analysis |
Rate of mortality
with ICD with usual care Absolute results not reported |
RR 0.74 95% CI 0.58 to 0.96 |
Small effect size | ICD |
[82]
Systematic review |
256 people with previous resuscitated cardiac arrest or symptomatic ventricular tachycardia (secondary prevention) 2 RCTs in this analysis |
Rate of mortality
with ICD with usual care Absolute results not reported |
RR 0.69 95% CI 0.39 to 1.24 The number analysed may have been too small to detect a significant difference |
Not significant | |
[83]
Systematic review |
934 women with heart failure and reduced left ventricular ejection fraction 5 RCTs in this analysis |
Mortality
with ICD with usual care Absolute results reported graphically |
HR 1.01 95% CI 0.76 to 1.33 P = 0.95 |
Not significant | |
Cardiac mortality | |||||
[81]
Systematic review |
4909 people 8 RCTs in this analysis |
Rate of cardiac mortality
124/2428 (5%) with ICD 339/2481 (14%) with usual care |
RR 0.43 95% CI 0.35 to 0.53 |
Moderate effect size | ICD |
[81]
Systematic review |
2946 people with evidence of heart failure or coronary artery disease (primary prevention) 5 RCTs in this analysis |
Rate of cardiac mortality
57/1494 (4%) with ICD 177/1452 (12%) with usual care |
RR 0.37 95% CI 0.27 to 0.50 The magnitude of absolute-mortality benefit increased with increasing baseline risk of sudden cardiac death There was significant heterogeneity among RCTs because 3 RCTs were in people at high risk of heart failure and 2 RCTs were in people at moderate risk of heart failure |
Moderate effect size | ICD |
[81]
Systematic review |
1963 people who had survived sudden cardiac death or had unstable ventricular rhythm (secondary prevention) 3 RCTs in this analysis |
Rate of cardiac mortality
67/934 (7%) with ICD 162/1029 (16%) with usual care |
RR 0.50 95% CI 0.38 to 0.66 |
Moderate effect size | ICD |